English
Press Release
30 April 2024
Cell and gene therapies, most notably CAR-T (chimeric antigen receptor) cells, are becoming increasingly important in cancer treatment. They are central to CellAction (Cell therapy Acceleration and Innovation), the brand-new Paris-Saclay Cancer Cluster (PSCC) platform at Institut Curie. CellAction's medical-scientific expertise and exceptional facilities make it a uniquely integrated structure in France. Thanks to public-private collaborations, projects can be launched to accelerate the development of innovative anti-cancer drugs, from basic research to their transfer to the clinic and to patients.
All
Medical
Scientific
Innovation
Generosity
Institutional
Event
Public health
No post
Get all multimedia resources (videos, podcasts, images, infographics) for our latest medical, scientific, institutional and event news here.
know more about the Institut Curie and our key figures, our activities...
For further information, please contact the press office